Overview
Betaine HCl (betaine hydrochloride) is an oral supplement derived from trimethylglycine (TMG) that serves a dual purpose: supporting stomach acid production and functioning as a methyl donor for cellular methylation pathways. While often discussed in fitness and performance circles, its primary clinical application is addressing hypochlorhydria—a condition of inadequate stomach acid production that impairs protein digestion and nutrient absorption.
Unlike standalone hydrochloric acid supplements, Betaine HCl combines acid support with the metabolic benefits of TMG, making it mechanistically distinct. The supplement is self-directed and available over-the-counter in most countries, with monthly costs ranging from $8–$30 depending on dosage and brand.
This guide reviews the current evidence across multiple health domains, dosing protocols, safety considerations, and practical application based on rigorous clinical research.
How It Works: Mechanism of Action
Betaine HCl operates through two complementary mechanisms:
Gastric Acid Support
When taken orally, Betaine HCl dissociates in the stomach to release hydrochloric acid, temporarily lowering gastric pH. This acidification reactivates pepsin, the protease enzyme essential for breaking down dietary proteins into absorbable amino acids. The acid environment also creates an inhospitable condition for pathogens, supporting the stomach's natural defense barrier.
This mechanism is particularly relevant for individuals with hypochlorhydria, where insufficient acid production impairs protein digestion and reduces the bioavailability of minerals like B12, iron, calcium, and zinc. By restoring pH conditions, Betaine HCl may improve nutrient absorption across these micronutrient classes.
Methylation & Homocysteine Metabolism
The betaine component acts as an osmolyte and methyl donor. Through the enzyme betaine-homocysteine methyltransferase (BHMT), betaine donates methyl groups to convert homocysteine to methionine—a critical amino acid and precursor to cellular methylation reactions. This supports the one-carbon cycle, which is essential for DNA synthesis, neurotransmitter production, and detoxification.
This dual action distinguishes Betaine HCl from isolated HCl supplements and explains its broader metabolic relevance beyond digestive support alone.
Evidence by Health Goal
The following section reviews clinical evidence for Betaine HCl across multiple health domains, organized by evidence tier (Tier 1 = no human efficacy data; Tier 2 = limited but promising data; Tier 3 = probable but mixed evidence).
Fat Loss — Tier 2 Evidence
Betaine supplementation shows mixed and contradictory effects on body composition. Earlier meta-analyses reported modest benefits, while more recent comprehensive analyses found no significant effects.
A earlier meta-analysis of 6 RCTs (n=195) reported betaine reduced body fat mass by 2.53 kg and body fat percentage by 2.44% versus placebo. However, a larger and more recent meta-analysis across multiple subgroups found betaine supplementation produced no significant change in body fat percentage (difference: 0.26%, p=0.663), fat mass (−0.57 kg, p=0.473), or body weight (−0.40 kg, p=0.447).
Bottom line: Evidence is inconclusive; Betaine is not recommended as a primary fat loss tool.
Muscle Growth & Strength — Tier 2 Evidence
Betaine shows modest improvements in athletic performance metrics but fails to drive meaningful hypertrophy or strength gains in controlled trials.
Meta-analysis data show betaine failed to improve fat-free mass (FFM gain: 0.61 kg, 95% CI −1.27 to 2.49, p=0.527) across multiple trials. However, CrossFit performance improved by 8.7% with 3 weeks of betaine supplementation (2.5–5.0 g/day) in trained subjects (n=43, p<0.001), though body composition did not change.
Lower body maximal strength showed a modest effect size of 0.49 (95% CI 0.01–0.98) in a 17-trial meta-analysis, while vertical jump performance improved with an effect size of 0.36 (95% CI 0.03–0.69). Upper body strength showed no significant benefit.
Bottom line: Betaine may modestly improve lower body strength and jumping ability in resistance-trained individuals, but does not reliably produce muscle hypertrophy or significant strength gains.
Injury Recovery — Tier 1 Evidence
Betaine HCl has not been studied for injury recovery in humans. Available evidence is limited to mechanistic reviews and animal studies exploring betaine's role in cellular metabolism. No direct evidence demonstrates efficacy for tissue repair or recovery from acute or chronic musculoskeletal injury.
Bottom line: Insufficient evidence; not recommended for injury recovery.
Anti-Inflammation — Tier 2 Evidence
Betaine shows plausible anti-inflammatory effects based on mechanistic understanding, but human evidence is limited and inconsistent.
A meta-analysis of 6 human RCTs (n=277) found IL-1β reduced by 0.65 pg/mL (95% CI −1.23 to −0.06), though with high heterogeneity (I²=95%). CRP, IL-6, and TNF-α showed no significant reductions. However, a 14-week RCT in youth soccer players (n=29) found that 2 g/day betaine significantly lowered TNF-α, IL-1β, and IL-6 at mid- and post-season compared to placebo.
Bottom line: Evidence is marginal; betaine may reduce certain inflammatory markers in athletes, but efficacy in general populations is not established.
Cognition — Tier 2 Evidence
Betaine shows mechanistic promise for cognition, particularly in specific neurological conditions, but human evidence is limited to case reports and small observational studies without adequately powered RCTs in healthy populations.
In two case reports of MTHFR deficiency patients, betaine supplementation decreased plasma homocysteine within 1 week and fully reversed cognitive decline, tremors, seizures, and behavioral symptoms within days to weeks. A systematic review of Alzheimer's disease (48 studies, 7009 patients) found betaine supplementation improved cognitive and functional outcomes, with decreased homocysteine and brain amyloid-β plaque levels.
Bottom line: Promising in specific neurological conditions, but insufficient evidence in healthy individuals.
Mood & Stress — Tier 2 Evidence
Betaine shows mechanistic promise through antioxidant and anti-inflammatory pathways, but human efficacy data is limited. Available reviews identify potential antidepressant effects in animal models and chronic stress contexts, but no human RCTs specifically measuring mood or stress outcomes have been identified.
Betaine does reliably reduce homocysteine (−1.30 μmol/L, 95% CI −1.61 to −0.98 in meta-analysis), a marker theoretically linked to mood and neurodegeneration, but this indirect evidence does not establish mood benefits.
Bottom line: Mechanistic promise, but no proven human efficacy for mood or stress.
Sleep — Tier 1 Evidence
Betaine HCl has no demonstrated efficacy for sleep. The only human RCT studying betaine for a neurological condition (Angelman syndrome) reported adverse events including worsening or onset of sleep disturbances, with no beneficial effects on any outcome measure and study withdrawal of 7 participants due to sleep problems.
Bottom line: No efficacy; may worsen sleep in some individuals.
Longevity & Aging — Tier 2 Evidence
Betaine shows mechanistic promise for longevity through effects on methylation, homocysteine reduction, and mitochondrial function, but human evidence demonstrating lifespan or aging outcomes is absent. Animal studies suggest potential; betaine extended lifespan in C. elegans via FoxO, p38-MAPK, autophagy, and mTOR pathway activation.
In postmenopausal women (n=42, 12-week RCT), choline supplementation increased median plasma betaine concentration and reduced plasma homocysteine by approximately 0.9 μmol versus a placebo increase of +0.6 μmol, approaching significance (p=0.058).
Bottom line: Animal data promising, but no human longevity evidence available.
Immune Support — Tier 2 Evidence
Betaine shows plausible immune-supporting effects in animals and limited human studies, with evidence of reduced pro-inflammatory cytokines. However, the human evidence base is small and lacks robust replication.
In a double-blind RCT (n≈60, 1 month), betaine reduced salivary IL-1β by significant margin (p=0.003, r=0.62) and TNF-α (p=0.001, r=0.69) versus placebo. The youth athlete study cited above (n=29, 14 weeks, 2g/day) also demonstrated cytokine reductions.
Bottom line: Limited evidence; may reduce inflammatory markers in some populations, but not definitively proven for immune function.
Energy & Performance — Tier 2 Evidence
Betaine shows plausible mechanisms for supporting energy metabolism and physical performance, but direct human evidence for 'energy' as a health outcome is mixed. CrossFit athletes (n=29, 6 weeks RCT) showed no improvement in aerobic or anaerobic capacity via Wingate tests or 2km rowing, though squat strength increased. In resistance-trained college students (n=24, RCT), a multi-ingredient pre-workout containing betaine increased isometric peak force, but betaine's isolated contribution was not established.
Bottom line: Limited direct evidence; may support lower body strength but not reliable for energy or endurance performance.
Skin & Hair — Tier 1 Evidence
Betaine HCl has no demonstrated efficacy for skin or hair health in humans. While animal studies suggest betaine may support collagen synthesis and fiber growth, no human clinical evidence proves it improves skin or hair outcomes.
Bottom line: No human evidence; not recommended for skin or hair health.
Gut Health — Tier 2 Evidence
Betaine HCl demonstrates plausible mechanisms for supporting gut health through microbiota modulation in animal models, but human evidence is limited to observational data. Maternal betaine supplementation increased milk betaine content and led to higher fecal Akkermansia muciniphila (a beneficial bacterium) abundance in human infants (observational study in 100+ infants in replication cohort).
In laying hens, dietary betaine increased intestinal villus height, villus-to-crypt ratio, upregulated tight junction expression, and enriched beneficial bacteria.
Bottom line: Mechanistic promise with preliminary human observational data, but no RCT confirmation in humans.
Heart Health — Tier 3 Evidence
Betaine supplementation reliably lowers homocysteine levels, a cardiovascular risk factor, but evidence for direct heart health benefits is mixed. A 21-day RCT (2.5–5.0 g/day betaine, n=20 healthy males) reduced homocysteine by 1.5 μmol/L (p=0.009).
However, most human studies show betaine does not improve blood pressure, triglycerides, or inflammatory markers. A meta-analysis of 6 RCTs showed betaine at doses ≥4 g/day increased total cholesterol by 0.34 mmol/L (95% CI 0.02–0.65, p=0.035), potentially offsetting homocysteine benefits.
Bottom line: Probable but mixed; homocysteine reduction is consistent, but cholesterol and clinical heart health effects are unclear.
Liver Health — Tier 3 Evidence
Betaine shows promise for liver health, particularly in reducing hepatic steatosis in obese populations, but evidence is limited to small pilot trials. A nutrient cocktail containing betaine reduced CAP scores (liver steatosis marker) by 4% and transient elastography (liver stiffness) by 7.8% in adults with obesity and metabolic-associated fatty liver disease over 3 months (n=155, double-blind RCT, p<0.05). However, betaine alone showed no effect on liver enzymes (ALT, AST, GGT) in healthy physically active males over 3 weeks.
Bottom line: Preliminary evidence in obese populations; clinical efficacy not conclusively proven.
Hormonal Balance — Tier 3 Evidence
Betaine shows probable benefits for hormonal markers in humans, with multiple RCTs demonstrating testosterone increases and cortisol decreases following resistance exercise.
Testosterone increased 7.0 ± 15.4% after 3 weeks of betaine supplementation in CrossFit athletes (n=43, RCT, p=0.046). Post-exercise cortisol decreased 41.5% (from 13 ± 3.4 to 7.6 ± 1.7 µg/dL) after 14 days of betaine in handball players (n=10, RCT, p=0.003, large effect size η²=0.49).
Bottom line: Probable benefits in resistance-trained athletes, but evidence is limited to small-sample studies with short intervention periods.
Sexual Health & Fertility — Tier 2 Evidence
Betaine shows plausible benefits for male fertility and semen quality based primarily on animal studies. In roosters exposed to chronic heat stress, betaine (1000 mg/kg) completely restored sperm concentration, livability, and fertility to control levels; seminal plasma antioxidant capacity increased significantly.
In 77 men with unexplained low fertilization rates (<60%), a multi-ingredient supplement containing betaine plus myo-inositol, alpha-lipoic acid, CoQ10, zinc, selenium, and B vitamins increased progressive motility and total motile sperm count (p=0.003), resulting in 29 clinical pregnancies in treatment cycles versus 0 pregnancies pre-treatment. However, this was an observational study without a control group, and betaine's isolated contribution is unclear.
Bottom line: Plausible in animal models; limited human evidence suggesting benefit as part of a multi-ingredient formula, but betaine alone not yet proven.
Athletic Performance — Tier 3 Evidence
Betaine supplementation shows probable efficacy for improving lower body strength and vertical jump in resistance-trained individuals, with modest improvements in some CrossFit tasks. A meta-analysis of 17 RCTs found lower body maximal strength improved with effect size of 0.49 (95% CI 0.01–0.98), while vertical jump improved with effect size of 0.36 (95% CI 0.03–0.69) after excluding low-quality studies. Upper body strength showed no significant effect.
Bottom line: Probable modest benefit for lower body strength and power in trained individuals; effects are inconsistent and small-to-moderate.